| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,155,700 | 1,119,100 | 1,135,100 | 1,147,800 | | Cost of Revenue | 666,300 | 669,200 | 673,500 | 656,000 | | | Gross Profit | 489,400 | 449,900 | 461,600 | 491,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 233,800 | 226,400 | 227,100 | 266,000 | | Non Recurring |
-
| 4,200 | 17,700 | 16,000 | | Others | 15,100 | 14,900 | 14,600 | 14,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 240,500 | 204,400 | 202,200 | 195,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (100) | (11,900) | 12,500 | (4,500) | | Earnings Before Interest And Taxes | 243,200 | 193,600 | 213,900 | 191,500 | | Interest Expense | 17,000 | 18,000 | 16,800 | 17,300 | | Income Before Tax | 226,200 | 175,600 | 197,100 | 174,200 | | Income Tax Expense | 90,400 | 67,700 | 75,000 | 73,600 | | Minority Interest |
-
| (3,100) | (3,000) | (3,600) | | | | Net Income From Continuing Ops | 135,800 | 118,100 | 111,900 | 104,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 135,800 | 118,100 | 111,900 | 104,200 | | Preferred Stock And Other Adjustments | (3,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $132,800 | $118,100 | $111,900 | $104,200 |
|
0.45% Nasdaq 
0.20%
Income Statement
